The Drug Regulatory Authority of Pakistan (DRAP) is upgrading its Central Drugs Laboratory (CDL) which will soon be accreditated by the World Health Organization (WHO).
A spokesperson for DRAP stated that it remains committed to safeguarding the quality of drugs in the country through the CDL project which is being upgraded to make DRAP a sophisticated regulator of medicinal products.
The CDL is currently receiving high-end equipment for drug testing, analytics, medicines, and related instruments. The spokesperson added that the World Health Organization will recommend practices for performing tests after the completion of the renovation.
The Central Drug Laboratory is being regularly assessed to ensure quality management and is engaged with the WHO to stay updated with quality control schematics as observed in WHO-certified labs overseas.
A peer audit by the WHO is expected to be conducted in April, subject to recurring feasibility reports from the concerned regulatory divisions.